Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid

EU orphan designation number: EU/3/05/277   
Active ingredient: (3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid
Indication: Treatment of cystic fibrosis
Sponsor: PTC Therapeutics, Limited
Lakeside House, Office G33a, 1 Furzeground Way, Stockley Park E. Uxbridge, UB11 1BD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Orphan Designation EMEA/OD/107/04 (2005)1650 of 27/05/2005
22/05/2007 Transfer of orphan designation EMEA/OD/107/04/T/01 (2007)2145 of 14/05/2007
07/05/2013 Transfer of orphan designation EMEA/OD/107/04/T/02 (2013)2734 of 03/05/2013
05/08/2014 Change of address of sponsor